Nuo Therapeutics, Inc.
AURX- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001091596
In the last 90 days, Nuo Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $4.28K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Nuo Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $9.54K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$9.54K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Nuo Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Jorden David Emerson | CEO/CFO | 2,070,000 | Aug 31, 2026 | 5 |
| Clausen Peter | CSO/COO | 770,054 | Jul 2, 2026 | 1 |
| Pittman Scott M. | Director, 10% Owner | 5,400,396 | Jul 2, 2026 | 3 |
| Winzer C Eric | Director | 173,050 | Jul 2, 2026 | 2 |
| Mintz Paul | Director | 108,294 | Jul 2, 2026 | 2 |
| Sheedy Charles E | 10% Owner | 11,570,833 | Aug 1, 2025 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 (view filing)10:29 AM ET | Aug 27-28 | 4 days | Jorden David EmersonCEO/CFO | PPurchase | +8.77K | $1.09 | +$9.54K | +0.4%2.07M after | Amended2 lots |
| Dec 3, 2025 (view filing) | Nov 28 | 5 daysLate | Jorden David EmersonCEO/CFO | SSale | −200.0K | $1.50 | −$300.0K | −9.3%1.95M after | |
| Aug 1, 2025 (view filing) | Jul 30 | 2 days | Sheedy Charles E10% Owner | PPurchase | +133.3K | $1.50 | +$200.0K | +1.2%11.6M after | |
| Sep 19, 2024 (view filing) | Sep 18 | 1 day | Sheedy Charles E10% Owner | PPurchase | +125.0K | $0.75 | +$93.8K | +1.1%11.4M after | |
| May 21, 2024 (view filing) | May 20 | 1 day | Sheedy Charles E10% Owner | PPurchase | +100.0K | $0.75 | +$75.0K | +0.9%11.3M after | |
| Dec 20, 2023 (view filing) | Dec 19 | 1 day | Sheedy Charles E10% Owner | PPurchase | +150.0K | $0.50 | +$75.0K | +1.4%11.2M after | |
| Aug 4, 2023 (view filing) | Aug 1 | 3 daysLate | Sheedy Charles E10% Owner | PPurchase | +62.5K | $2.00 | +$125.0K | +0.6%11.1M after | |
| Nov 14, 2022 (view filing) | Nov 9 | 5 days | Jorden David EmersonCEO/CFO | SSale | −162.5K | $1.50 | −$243.8K | −7.6%1.98M after | 9 lots |
| May 2, 2022 (view filing) | Apr 29 | 3 days | Sheedy Charles E10% Owner | PPurchase | +804.9K | $1.00 | +$804.9K | +7.9%11.0M after |